Methylenetetrahydrofolate reductase polymorphism in healthy volunteers and its correlation with homocysteine levels in patients with thrombosis
- PMID: 31571711
- PMCID: PMC6759526
- DOI: 10.4103/ijp.IJP_215_19
Methylenetetrahydrofolate reductase polymorphism in healthy volunteers and its correlation with homocysteine levels in patients with thrombosis
Abstract
Objective: To determine prevalence of methylenetetrahydrofolate reductase (MTHFR) mutations in apparently healthy individuals residing in Mumbai and patients with deep vein thrombosis (DVT) and coronary artery disease (CAD) and to correlate these polymorphisms with homocysteine (Hcy) levels.
Materials and methods: This case-control study was initiated after receiving ethical approval and following the participant's written consent. One hundred and twenty unmatched healthy volunteers and 240 patients with arterial and venous thrombosis were enrolled. The prevalence of C677T and A1298C MTHFR mutations was detected using polymerase chain reaction-restriction fragment length polymorphism technique. Serum Hcy concentration and lipid levels were determined using biochemical kits.
Results: Allele frequency of 677T was 7%, 15%, and 14% in healthy controls, DVT, and CAD patients, respectively, while for 1298C allele, it was 31%, 33%, and 29%, respectively. The lipid markers in CAD patients were significantly low in comparison to the controls while the Hcy level in patients with thrombosis was higher in comparison with the controls. Highest Hcy levels were observed in participants with TT genotype followed by CT genotype and CC genotype in all the three groups. A higher risk of raised Hcy levels was seen in the variants (CT + TT) as compared to CC genotype in DVT (odds ratio [OR] = 3.39, 95% confidence interval [CI] = 1.39-8.2,P < 0.01) and CAD (OR = 21.67, 95%CI = 4.87-96.47,P < 0.0001). The risk observed for A1298C was 2.28 and 2.12 times higher in variants (AC + CC) of both DVT and CAD (OR = 2.28, 95%CI = 1.09-4.75 and OR = 2.12, 95%CI = 1.02-4.40, respectively).
Conclusions: The prevalence of variants was more in thrombosis patients as compared to unmatched controls. Our study highlights the fact that MTHFR C677T polymorphism as compared to A1298C significantly affects Hcy levels in patients with thrombosis indicating that patients with mutant variants are at higher risk of rapid progression of their disease condition.
Keywords: Coronary artery disease; deep vein thrombosis; healthy volunteers; homocysteine; methylenetetrahydrofolate reductase polymorphism.
Copyright: © 2019 Indian Journal of Pharmacology.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults.Cell Biochem Funct. 2014 Jan;32(1):1-4. doi: 10.1002/cbf.3019. Epub 2013 Nov 26. Cell Biochem Funct. 2014. PMID: 24277487
-
Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India.Metab Brain Dis. 2018 Oct;33(5):1617-1624. doi: 10.1007/s11011-018-0268-5. Epub 2018 Jun 21. Metab Brain Dis. 2018. PMID: 29926428
-
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.Clin Chem. 2001 Apr;47(4):661-6. Clin Chem. 2001. PMID: 11274015
-
Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.Am J Cardiovasc Drugs. 2001;1(5):353-61. doi: 10.2165/00129784-200101050-00005. Am J Cardiovasc Drugs. 2001. PMID: 14728017 Review.
-
Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21. J Vasc Surg. 2009. PMID: 19157768 Review.
Cited by
-
Methylenetetrahydrofolate Reductase Gene Polymorphism as a Risk Factor for Coronary Artery Disease.Indian J Clin Biochem. 2025 Jan;40(1):25-31. doi: 10.1007/s12291-023-01162-z. Epub 2023 Nov 23. Indian J Clin Biochem. 2025. PMID: 39835231 Review.
-
Antibody-drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management.Indian J Pharmacol. 2020 Sep-Oct;52(5):402-413. doi: 10.4103/ijp.IJP_475_18. Indian J Pharmacol. 2020. PMID: 33283772 Free PMC article. Review.
-
Relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and neutrophil gelatinase-associated lipocalin in early renal injury in H-type hypertension.BMC Cardiovasc Disord. 2024 Jan 18;24(1):55. doi: 10.1186/s12872-024-03704-6. BMC Cardiovasc Disord. 2024. PMID: 38238653 Free PMC article.
-
C677T Gene Polymorphism of MTHFR Is a Risk Factor for Impaired Renal Function in Pregnant Women With Preeclampsia in the Chinese Han Population.Front Cardiovasc Med. 2022 May 30;9:902346. doi: 10.3389/fcvm.2022.902346. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35711354 Free PMC article.
-
Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis.Int J Mol Sci. 2020 Jun 15;21(12):4259. doi: 10.3390/ijms21124259. Int J Mol Sci. 2020. PMID: 32549393 Free PMC article. Review.
References
-
- Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–32. - PubMed
-
- McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998;13:235–9. - PubMed
-
- de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E, et al. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005;19:42–6. - PubMed
-
- Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149–51. - PubMed
-
- Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet. 1997;349:1591–3. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous